Thrombin

DB11300ApprovedInvestigationalProtein Based TherapiesBlood Coagulation Factors

Thrombin is a coagulation factor used to stop bleeding during surgery. Also known as coagulation factor II, thrombin is a serine protease that plays a physiological role in regulating hemostasis and maintaining blood coagulation.

Protein structure of Thrombin
Mechanism
Curator reviewed
Primary indication
Bovine thrombin is a topical thrombin indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (like suture, ligature, or...Curator reviewed · 2 structured indications
First approval
Canada, 2001 · United States, 1995
Also known as
coagulation factor II · Thrombin bovine · Thrombin, Topical (Bovine)
Brand names
  • Thrombin-jmi

Resolves to

What you can answer from here — as of February 01, 2025

10Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Drug interactionStructured to mechanism, not free text
Sign in
50Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
56Marketed productsAcross 7 countries and 13 labellers
Sign in
2ATC codesIncluding every combination product, plus 21 drug categories
Sign in
13+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Thrombin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account